Derma AI Earns CE Mark Approval
The AI dermatology medical device has gained approval for 27 countries within the European Union
News provided by
Share this article
Share this article
PERTH, Australia, May 27, 2021 /PRNewswire/ Advanced Human Imaging Limited (ASX: AHI) ( AHI or the Company ) is pleased to announce the Derma AI embedded in the AHI DermaScan has received CE Mark clearance in the European Union for the dermatology AI component in CompleteScan.
The Derma AI component (DermaScan AI) can accurately classify skin conditions from an image captured on a standard smartphone camera. Using the largest proprietary database of its kind in the world, the Derma AI can classify 588 common or rare skin conditions in 133 categories – including all categories of skin cancer.